Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samy Hadjadj

Showing results (171-180 of 217) with videos related to

Pageof 22
Sort By:
Plos One|February 14, 2013
What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?Amélie Bonnefond, Pierre-Jean Saulnier, Maria G Stathopoulou, et al.
Diabetologia|December 6, 2014
SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetesMarine Germain, Marcus G Pezzolesi, Niina Sandholm, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 16, 2016
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversionFaiez Zannad, Wendy Gattis Stough, Raymond J Lipicky, et al.
Diabetes, Obesity & Metabolism|April 3, 2020
Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 studyAvivit Cahn, Itamar Raz, Marc Bonaca, et al.
European Journal of Endocrinology|October 12, 2021
Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort studyMaelle Le Bras, Hélène Leclerc, Olivia Rousseau, et al.
Diabetes & Metabolic Syndrome|April 26, 2022
Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European studySophie Harris, Yue Ruan, Sarah H Wild, et al.
Diabetes Technology & Therapeutics|July 10, 2026
Sustained Follow-up of Automated Insulin Delivery in a Real-World Setting: Results at 2 Years of the French Nationwide Observatory OB2FJean-Baptiste Julla, Chloé Amouyal, Sandrine Lablanche, et al.
Gastroenterology|October 25, 2019
Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover TrialPhilippe Ducrotte, Benoit Coffin, Bruno Bonaz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 15, 2020
Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre StudyGuillaume Gourcerol, Benoit Coffin, Bruno Bonaz, et al.
Frontiers in Endocrinology|March 17, 2023
Four missense genetic variants in <i>CUBN</i> are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in EuropeansNicoline Uglebjerg, Fariba Ahmadizar, Dina M Aly, et al.
Pageof 22

Showing results (171-180 of 217) with videos related to

Sort By:
Pageof 22
Plos One|February 14, 2013
What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?Amélie Bonnefond, Pierre-Jean Saulnier, Maria G Stathopoulou, et al.
Diabetologia|December 6, 2014
SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetesMarine Germain, Marcus G Pezzolesi, Niina Sandholm, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 16, 2016
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversionFaiez Zannad, Wendy Gattis Stough, Raymond J Lipicky, et al.
Diabetes, Obesity & Metabolism|April 3, 2020
Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE-TIMI 58 studyAvivit Cahn, Itamar Raz, Marc Bonaca, et al.
European Journal of Endocrinology|October 12, 2021
Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort studyMaelle Le Bras, Hélène Leclerc, Olivia Rousseau, et al.
Diabetes & Metabolic Syndrome|April 26, 2022
Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European studySophie Harris, Yue Ruan, Sarah H Wild, et al.
Diabetes Technology & Therapeutics|July 10, 2026
Sustained Follow-up of Automated Insulin Delivery in a Real-World Setting: Results at 2 Years of the French Nationwide Observatory OB2FJean-Baptiste Julla, Chloé Amouyal, Sandrine Lablanche, et al.
Gastroenterology|October 25, 2019
Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover TrialPhilippe Ducrotte, Benoit Coffin, Bruno Bonaz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 15, 2020
Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre StudyGuillaume Gourcerol, Benoit Coffin, Bruno Bonaz, et al.
Frontiers in Endocrinology|March 17, 2023
Four missense genetic variants in <i>CUBN</i> are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in EuropeansNicoline Uglebjerg, Fariba Ahmadizar, Dina M Aly, et al.
Pageof 22